Article Information
vol. 60 no. suppl 66
Published By
Print ISSN
Online ISSN
History
- Published online January 24, 2023.
Copyright & Usage
Copyright ©the authors 2022
Author Information
- Andrew Menzies-Gow1⇑,
- Michael E. Wechsler2,
- Christopher E. Brightling3,
- Stephanie Korn4,
- Artur Bednarczyk5,
- Sandhia Ponnarambil6,
- Gun Almqvist7,
- Kaitlyn Lawson8,
- Scott Caveney9,
- Karin Bowen10 and
- Gene Colice11
- 1Royal Brompton and Harefield Hospitals, London, United Kingdom
- 2National Jewish Health, Denver, CO, United States
- 3Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom
- 4IKF Pneumologie Mainz, Mainz, Germany and Thoraxklinik Heidelberg, Heidelberg, Germany
- 5Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland
- 6Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
- 7Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 8Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA and Cytel, Inc, Cambridge, MA, United States
- 9Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, United States
- 10Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States
- 11Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States
- Andrew Menzies-Gow, Royal Brompton and Harefield Hospitals, London, United Kingdom. E-mail: a.menzies-gow{at}rbht.nhs.uk
Article usage
Altmetrics
Vol 60 Issue suppl 66
Table of Contents
Late Breaking Abstract - DESTINATION: tezepelumab long-term safety and efficacy versus placebo in patients with severe, uncontrolled asthma
